Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Biochemical and immunological properties of cytokines conjugated to dendritic polymers.

Lee SC, Parthasarathy R, Botwin K, Kunneman D, Rowold E, Lange G, Klover J, Abegg A, Zobel J, Beck T, Miller T, Hood W, Monahan J, McKearn JP, Jansson R, Voliva CF.

Biomed Microdevices. 2004 Sep;6(3):191-202.

PMID:
15377828
2.

Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.

Huang RQ, Qu YH, Ke WL, Zhu JH, Pei YY, Jiang C.

FASEB J. 2007 Apr;21(4):1117-25. Epub 2007 Jan 11.

PMID:
17218540
3.

Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.

Kobayashi H, Wu C, Kim MK, Paik CH, Carrasquillo JA, Brechbiel MW.

Bioconjug Chem. 1999 Jan-Feb;10(1):103-11.

PMID:
9893971
4.

Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload.

Kolhe P, Khandare J, Pillai O, Kannan S, Lieh-Lai M, Kannan RM.

Biomaterials. 2006 Feb;27(4):660-9. Epub 2005 Jul 27.

PMID:
16054211
5.

Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery.

Zhang XQ, Intra J, Salem AK.

Bioconjug Chem. 2007 Nov-Dec;18(6):2068-76. Epub 2007 Sep 12.

PMID:
17848077
6.

Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

Malik N, Wiwattanapatapee R, Klopsch R, Lorenz K, Frey H, Weener JW, Meijer EW, Paulus W, Duncan R.

J Control Release. 2000 Mar 1;65(1-2):133-48. Erratum in: J Control Release 2000 Aug 10;68(2):299-302.

PMID:
10699277
7.

Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers.

Pisal DS, Yellepeddi VK, Kumar A, Palakurthi S.

Drug Deliv. 2008 Nov;15(8):515-22. doi: 10.1080/10717540802321826 .

PMID:
18720134
8.

Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.

Patri AK, Kukowska-Latallo JF, Baker JR Jr.

Adv Drug Deliv Rev. 2005 Dec 14;57(15):2203-14. Epub 2005 Nov 14.

PMID:
16290254
9.

Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers.

Wilbur DS, Pathare PM, Hamlin DK, Buhler KR, Vessella RL.

Bioconjug Chem. 1998 Nov-Dec;9(6):813-25.

PMID:
9815176
10.

Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.

Shukla S, Wu G, Chatterjee M, Yang W, Sekido M, Diop LA, Müller R, Sudimack JJ, Lee RJ, Barth RF, Tjarks W.

Bioconjug Chem. 2003 Jan-Feb;14(1):158-67.

PMID:
12526705
11.

Nanoscale protein pores modified with PAMAM dendrimers.

Martin H, Kinns H, Mitchell N, Astier Y, Madathil R, Howorka S.

J Am Chem Soc. 2007 Aug 8;129(31):9640-9. Epub 2007 Jul 18.

PMID:
17636906
12.

The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress.

Wang W, Xiong W, Wan J, Sun X, Xu H, Yang X.

Nanotechnology. 2009 Mar 11;20(10):105103. doi: 10.1088/0957-4484/20/10/105103. Epub 2009 Feb 16.

PMID:
19417510
13.

Molecular dynamics simulation of polyamidoamine dendrimer-fullerene conjugates: generations zero through four.

Kujawski M, Rakesh L, Gala K, Jensen A, Fahlman B, Feng ZR, Mohanty DK.

J Nanosci Nanotechnol. 2007 Apr-May;7(4-5):1670-4.

PMID:
17450941
14.

Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles.

Gaertner HF, Cerini F, Kamath A, Rochat AF, Siegrist CA, Menin L, Hartley O.

Bioconjug Chem. 2011 Jun 15;22(6):1103-14. doi: 10.1021/bc1005653. Epub 2011 May 31.

PMID:
21574642
15.

Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.

Ke W, Shao K, Huang R, Han L, Liu Y, Li J, Kuang Y, Ye L, Lou J, Jiang C.

Biomaterials. 2009 Dec;30(36):6976-85. doi: 10.1016/j.biomaterials.2009.08.049. Epub 2009 Sep 17.

PMID:
19765819
16.

[In vivo expression of green fluorescent protein gene and immunogenicity of ES312 vaccine both mediated by starburst polyamidoamine dendrimers].

Ding JJ, Guo CY, Cai QL, Lin YH, Wang H.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Aug;27(4):499-503. Chinese.

PMID:
16178448
17.

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

Zhu S, Hong M, Tang G, Qian L, Lin J, Jiang Y, Pei Y.

Biomaterials. 2010 Feb;31(6):1360-71. doi: 10.1016/j.biomaterials.2009.10.044. Epub 2009 Nov 2.

PMID:
19883938
18.

Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.

Han L, Huang R, Liu S, Huang S, Jiang C.

Mol Pharm. 2010 Dec 6;7(6):2156-65. doi: 10.1021/mp100185f. Epub 2010 Oct 14.

PMID:
20857964
19.

Reactive oxygen species (ROS) induced cytokine production and cytotoxicity of PAMAM dendrimers in J774A.1 cells.

Naha PC, Davoren M, Lyng FM, Byrne HJ.

Toxicol Appl Pharmacol. 2010 Jul;246(1-2):91-9. doi: 10.1016/j.taap.2010.04.014. Epub 2010 Apr 24.

PMID:
20420846
20.

Incorporation of fluorescent probes into PAMAM dendrimers.

Domański DM, Klajnert B, Bryszewska M.

Bioelectrochemistry. 2004 Jun;63(1-2):193-7.

PMID:
15110272

Supplemental Content

Support Center